Health Library › Conditions › Lymphofollicular hyperplasia
Condition
Lymphofollicular hyperplasia is a usually benign enlargement of immune-cell clusters within tissue, often in the digestive tract.
Lymphofollicular hyperplasia means that small clusters of immune cells, called lymphoid follicles, have become larger or more numerous than usual. “Hyperplasia” means an increase in the number of cells. This is usually a reactive, non-cancerous change.
Lymphoid follicles are normal parts of the immune system. They help the body recognize and respond to infections and other substances. They are found in lymph nodes and in tissues such as the tonsils, appendix, stomach, small intestine, and colon.
The term is often used in a pathology or endoscopy report. In the digestive tract, the follicles may appear as many small, rounded bumps. This may be called nodular lymphoid hyperplasia. A single prominent follicle may also be described as lymphofollicular hyperplasia.
This finding matters because it sometimes points to ongoing immune stimulation. Possible triggers include an intestinal infection, inflammation, or an immune-system condition. In other people, no cause is found and the change causes no health problems.
Lymphofollicular hyperplasia is not the same as lymphoma. Lymphoma is a cancer of lymphocytes, which are immune cells. Reactive follicles generally keep an organized, normal-looking structure under the microscope. A biopsy allows a pathologist to check this distinction.
The significance of the finding depends on its location, your symptoms, the biopsy appearance, and whether you have another medical condition. An isolated, incidental finding may need no treatment. More widespread changes or persistent symptoms may lead to further testing.
Many people have no symptoms. The hyperplasia may be found during an endoscopy, scan, operation, or examination performed for another reason.
When it affects the digestive tract, possible symptoms include:
These symptoms are not specific to lymphofollicular hyperplasia. They can come from an associated infection or inflammatory condition rather than from the enlarged follicles themselves.
Rarely, very prominent intestinal follicles may contribute to bleeding or narrowing of the bowel. In children, enlarged lymphoid tissue can occasionally act as a leading point for intussusception, in which one section of bowel slides into another.
Hyperplasia in other locations produces different effects. Enlarged follicles in the tonsils or adenoids, for example, may be associated with throat symptoms or nasal blockage. The wording of the pathology report and the tissue sampled are therefore important.
Lymphofollicular hyperplasia usually represents an immune reaction. Immune cells multiply within a follicle after they encounter germs, food-related antigens, or other substances that stimulate the immune system.
In the digestive tract, reported associations include infections such as Giardia and Helicobacter pylori. Giardia is a parasite that can cause diarrhea, cramps, and poor nutrient absorption. H. pylori is a bacterium that infects the stomach lining.
The finding has also been associated with conditions affecting immune function. One example is common variable immunodeficiency, or CVID, in which the body does not make enough effective antibodies. Some people are first assessed for an immune disorder after widespread intestinal lymphoid nodules are found.
Other possible associations include food-related immune reactions, inflammatory bowel conditions, and coeliac disease. An association does not mean that one of these conditions is present. Testing should be guided by the location of the hyperplasia, symptoms, medical history, and biopsy results.
Sometimes no clear trigger is identified. This is especially possible when the finding is small, limited to one area, and discovered by chance.
Lymphofollicular hyperplasia itself is not generally considered inherited. However, a small number of associated immune disorders can run in families.
The finding may first be seen during an endoscopy. An endoscope is a thin, flexible camera used to examine areas such as the stomach, small intestine, or colon. The follicles can look like small pale or rounded nodules, but appearance alone cannot confirm what they are.
Confirmation usually requires a biopsy. During a biopsy, a small tissue sample is removed and examined under a microscope. The pathologist looks at the arrangement and appearance of the immune cells. Additional laboratory stains or cell tests may be used if the pattern is unusual or lymphoma needs to be excluded.
The next step depends on why the biopsy was taken. If the finding is clearly reactive and you have no concerning symptoms, further investigation may be limited.
When symptoms are present or the hyperplasia is widespread, testing may include:
A report containing words such as “reactive,” “preserved architecture,” or “polyclonal” generally supports a non-cancerous immune response. “Polyclonal” means that many different immune-cell families are present, as expected in a normal reaction. Your report must still be interpreted in its full clinical context.
Lymphofollicular hyperplasia does not always need treatment. If it was found by chance, looks clearly benign, and is not causing symptoms, observation may be appropriate.
When an underlying cause is identified, management focuses on that cause. This might involve treatment for a confirmed infection, care for an immune deficiency, or management of an inflammatory digestive condition. The treatment differs substantially between these conditions, so the finding alone does not determine which treatment is suitable.
Symptoms such as diarrhea, anemia, or nutrient deficiency may also require supportive care while their cause is investigated. People with an antibody deficiency may need specialist immunology care. Treating the associated condition may improve the lymphoid hyperplasia, although the nodules do not always disappear completely.
Surgery is not a routine treatment for uncomplicated hyperplasia. It may be needed in the uncommon situation where there is significant bleeding, bowel blockage, intussusception, or uncertainty about a mass that cannot be resolved with smaller biopsies.
There is no single follow-up schedule for everyone with this finding. Follow-up is based on symptoms, the biopsy result, the extent of the changes, and any associated immune condition. Repeat endoscopy may be considered in selected cases, but routine repeated procedures are not necessary for every incidental finding.
Most reactive lymphofollicular hyperplasia remains benign and causes no direct complications.
Possible complications in the digestive tract include persistent diarrhea, nutrient deficiencies, anemia, or weight loss. These often arise from an underlying infection or immune condition rather than from the follicles alone.
Less common complications include intestinal bleeding, narrowing or blockage of the bowel, and intussusception. These are more likely to cause sudden or significant symptoms.
Some reports have linked extensive nodular lymphoid hyperplasia with a later risk of intestinal lymphoma, particularly when an immune deficiency is also present. This does not mean that lymphofollicular hyperplasia usually becomes cancer. The absolute risk for an individual cannot be determined from the term alone. New symptoms, changing lesions, or an atypical biopsy may justify closer assessment.
There is no established way to prevent lymphofollicular hyperplasia itself. It is an immune response rather than a single disease with one avoidable cause.
Some associated infections can be reduced through safe food and water practices and careful handwashing. This does not prevent cases caused by other immune triggers.
Inherited or acquired immune deficiencies cannot be prevented through lifestyle changes. Early recognition and treatment of associated infections may reduce symptoms and complications, but it cannot guarantee that enlarged follicles will resolve.
For many people, lymphofollicular hyperplasia is an incidental, stable finding. If the biopsy is reassuring and there are no ongoing symptoms, it may have little or no effect on daily life.
When the hyperplasia is linked to an infection, symptoms may improve after the infection is cleared. The tissue changes may take longer to settle and can sometimes remain visible even after you feel better.
If an immune deficiency or chronic digestive condition is found, the longer-term course is shaped mainly by that condition. Care may include periodic blood tests, treatment of infections, nutritional monitoring, or follow-up with gastroenterology or immunology.
Keep a record of the tissue location and the wording of the biopsy result. “Lymphofollicular hyperplasia” in the stomach, appendix, colon, or a lymph node can have different clinical meanings.
Arrange routine follow-up if symptoms continue, return, or gradually change. Persistent diarrhea, recurring infections, weight loss, anemia, or blood in the stool deserves assessment even when a previous biopsy was benign.
Arrange a routine medical appointment if you have ongoing diarrhea, recurrent abdominal pain, unexplained fatigue, reduced appetite, or repeated infections. Also seek review if you are losing weight without trying or notice small amounts of blood in your stool.
If you already have a diagnosis, contact your care team if symptoms become more frequent or if a follow-up plan is unclear. A new symptom does not necessarily mean the tissue has become cancerous, but it may need investigation.
Seek urgent medical care for:
Call emergency services for heavy bleeding, collapse, severe breathing difficulty, or sudden intense abdominal pain with signs of serious illness.
Is lymphofollicular hyperplasia cancer?
Usually not. It most often describes a benign immune reaction. A biopsy is important because some lymphomas can resemble reactive lymphoid tissue during an endoscopy or scan. The microscopic pattern helps distinguish them.
Does lymphofollicular hyperplasia turn into lymphoma?
Most cases do not. Extensive intestinal hyperplasia has been associated with lymphoma in some reports, particularly in people with an immune deficiency. This is an association, not proof that the hyperplasia will transform. Individual follow-up is based on the biopsy and other risk factors.
Why was it found if I have no symptoms?
Normal lymphoid tissue can become prominent after immune stimulation and may be noticed during a test performed for another reason. Modern endoscopy and routine tissue sampling can detect small changes that would otherwise remain unknown.
Do the lymphoid follicles need to be removed?
Usually not. Benign follicles are generally left in place. Treatment focuses on a confirmed infection or associated condition. Removal may be considered if there is a complication, a discrete mass, or uncertainty that cannot be resolved by biopsy.
Can lymphofollicular hyperplasia go away?
It can become less prominent after an infection or another trigger is treated. In other cases, it remains stable without causing problems. Persistent follicles do not automatically mean that treatment has failed.
Is lymphofollicular hyperplasia the same as swollen lymph nodes?
No. Both involve immune tissue, but lymphofollicular hyperplasia describes a microscopic growth pattern that can occur inside a lymph node or another organ. A swollen lymph node is a physical enlargement with many possible causes.
sofidex [Internet]. Daloreum; c2026. Lymphofollicular hyperplasia; [reviewed 2026 Aug 20; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/conditions/lymphofollicular-hyperplasia
sofidex. (2026, August 20). Lymphofollicular hyperplasia. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/conditions/lymphofollicular-hyperplasia
Lymphofollicular hyperplasia. sofidex. Reviewed August 20, 2026. Accessed November 10, 2026. https://sofidex.com/patients/conditions/lymphofollicular-hyperplasia
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.